window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision Medicine

  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    UK national cancer plan aims to boost survival and cut inequalities in diagnosis and treatment

    The UK Government this World Cancer Day has published its [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    €1 million investment for BiPER Therapeutics to launch BPR001-615 BiP inhibitor trial

    BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Genomics and sequencing

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    May 5, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    UK nuclear materials to power new precision cancer therapies

    The UK is launching a major programme to convert used [...]

    May 5, 2026
  • Drug Discovery & Development,Genomics and sequencing

    SPT Labtech and Agilent launch automated target enrichment workflows for genomic sequencing

    SPT Labtech and Agilent Technologies have introduced automated target enrichment [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    CTMC and Einstein Hospital Israelita launch global cell therapy alliance

    CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Olorofim meets primary endpoint in phase 3 OASIS aspergillosis study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Spot Biosystems reports early clinical evidence for non-viral dystrophin delivery in Duchenne muscular dystrophy
    Categories: Advanced Therapies, Drug Discovery & Development
  • Neurizon strengthens manufacturing base with Elanco supply deal for ALS asset
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top